Literature DB >> 7438122

Vindesine trials at Memorial Sloan-Kettering Cancer Center.

C W Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7438122     DOI： 10.1016/s0305-7372(80)80008-9

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  5 in total

1.  Vindesine in head and neck cancer. A Southwest Oncology Group Phase II pilot study.

Authors:  C D Haas; C J Fabian; R L Stephens; J Kish
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

2.  Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.

Authors:  B T Hill; R D Whelan
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer.

Authors:  S G Allan; A Gregor; M A Cornbleet; R C Leonard; J F Smyth; I W Grant; G K Crompton
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activity.

Authors:  R Pazdur; A H Rossof; G Chandra; P D Bonomi; R E Slayton; J Wolter
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  Vindesine receptors in cells of a human leukaemia cell line.

Authors:  K Totsuka; K Oshimi; H Mizoguchi
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.